Apc bridges Wnt/β-catenin and BMP signaling during osteoblast differentiation of KS483 cells

Experimental Cell Research

Volumn 317, Issue 10, 2011, Pages 1411-1421

  Miclea, Razvan L ^a   van der Horst, Geertje ^a   Robanus Maandag, Els C ^a   Löwik, Clemens W G M ^a   Oostdijk, Wilma ^a   Wit, Jan M ^a   Karperien, Marcel ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

Apc; Differentiation; Osteoblast; Wnt; Catenin

Indexed keywords

BETA CATENIN; BONE MORPHOGENETIC PROTEIN; OSTEOGENIC PROTEIN 1; SMALL INTERFERING RNA; WNT PROTEIN;

ADIPOCYTE; ANIMAL CELL; APOPTOSIS; ARTICLE; CARTILAGE CELL; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CELL SHAPE; CELL STRAIN KS483; CELL STRUCTURE; COLON POLYPOSIS; CONTROLLED STUDY; CULTURE MEDIUM; MESENCHYME CELL; MOLECULAR MECHANICS; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; STEM CELL;

MURINAE;

EID: 79955979024     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2011.03.007     Document Type: Article

References (56)

1. Ahmed Y., Hayashi S., Levine A., Wieschaus E. Regulation of armadillo by a Drosophila APC inhibits neuronal apoptosis during retinal development. Cell 1998, 93:1171-1182.
2. Bain G., Muller T., Wang X., Papkoff J. Activated beta-catenin induces osteoblast differentiation of C3H10T1/2 cells and participates in BMP2 mediated signal transduction. Biochem. Biophys. Res. Commun. 2003, 301:84-91.
3. Benchabane H., Ahmed Y. The adenomatous polyposis coli tumor suppressor and Wnt signaling in the regulation of apoptosis. Adv. Exp. Med. Biol. 2009, 656:75-84.
4. Bessa P.C., Casal M., Reis R.L. Bone morphogenetic proteins in tissue engineering: the road from the laboratory to the clinic, part I (basic concepts). J. Tissue Eng. Regen. Med. 2008, 2:1-13.
5. Carson D.J., Santoro I.M., Groden J. Isoforms of the APC tumor suppressor and their ability to inhibit cell growth and tumorigenicity. Oncogene 2004, 23:7144-7148.
6. Chen M., Zhu M., Awad H., Li T.F., Sheu T.J., Boyce B.F., Chen D., O'Keefe R.J. Inhibition of beta-catenin signaling causes defects in postnatal cartilage development. J. Cell Sci. 2008, 121:1455-1465.
7. Chen Y., Whetstone H.C., Youn A., Nadesan P., Chow E.C., Lin A.C., Alman B.A. Beta-catenin signaling pathway is crucial for bone morphogenetic protein 2 to induce new bone formation. J. Biol. Chem. 2007, 282:526-533.
8. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 2006, 127:469-480.
9. Doench J.G., Petersen C.P., Sharp P.A. siRNAs can function as miRNAs. Genes Dev. 2003, 17:438-442.
10. Faux M.C., Ross J.L., Meeker C., Johns T., Ji H., Simpson R.J., Layton M.J., Burgess A.W. Restoration of full-length adenomatous polyposis coli (APC) protein in a colon cancer cell line enhances cell adhesion. J. Cell Sci. 2004, 117:427-439.
11. Fischer L., Boland G., Tuan R.S. Wnt signaling during BMP-2 stimulation of mesenchymal chondrogenesis. J. Cell. Biochem. 2002, 84:816-831.
12. Fodde R. The multiple functions of tumour suppressors: it's all in APC. Nat. Cell Biol. 2003, 5:190-192.
13. Gaspar C., Fodde R. APC dosage effects in tumorigenesis and stem cell differentiation. Int. J. Dev. Biol. 2004, 48:377-386.
14. Guo X., Wang X.F. Signaling cross-talk between TGF-beta/BMP and other pathways. Cell Res. 2009, 19:71-88.
15. Haertel-Wiesmann M., Liang Y., Fantl W.J., Williams L.T. Regulation of cyclooxygenase-2 and periostin by Wnt-3 in mouse mammary epithelial cells. J. Biol. Chem. 2000, 275:32046-32051.
16. Hanson C.A., Miller J.R. Non-traditional roles for the adenomatous polyposis coli (APC) tumor suppressor protein. Gene 2005, 361:1-12.
17. Hartmann C. A Wnt canon orchestrating osteoblastogenesis. Trends Cell Biol. 2006, 16:151-158.
18. Hartmann C. Transcriptional networks controlling skeletal development. Curr. Opin. Genet. Dev. 2009, 19:437-443.
19. Henderson B.R. Nuclear-cytoplasmic shuttling of APC regulates beta-catenin subcellular localization and turnover. Nat. Cell Biol. 2000, 2:653-660.
20. Holmen S.L., Zylstra C.R., Mukherjee A., Sigler R.E., Faugere M.C., Bouxsein M.L., Deng L., Clemens T.L., Williams B.O. Essential role of beta-catenin in postnatal bone acquisition. J. Biol. Chem. 2005, 280:21162-21168.
21. Hussein S.M., Duff E.K., Sirard C. Smad4 and beta-catenin co-activators functionally interact with lymphoid-enhancing factor to regulate graded expression of Msx2. J. Biol. Chem. 2003, 278:48805-48814.
22. Jho E.H., Zhang T., Domon C., Joo C.K., Freund J.N., Costantini F. Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol. Cell. Biol. 2002, 22:1172-1183.
23. Kamiya N., Kobayashi T., Mochida Y., Yu P.B., Yamauchi M., Kronenberg H.M., Mishina Y. Wnt inhibitors Dkk1 and sost are downstream targets of BMP signaling through the type IA receptor (BMPRIA) in osteoblasts. J. Bone Miner. Res. 2009.
24. Karsenty G. The complexities of skeletal biology. Nature 2003, 423:316-318.
25. Karsenty G., Kronenberg H.M., Settembre C. Genetic control of bone formation. Annu. Rev. Cell Dev. Biol. 2009, 25:629-648.
26. Kielman M.F., Rindapaa M., Gaspar C., van Poppel N., Breukel C., van Leeuwen S., Taketo M.M., Roberts S., Smits R., Fodde R. Apc modulates embryonic stem-cell differentiation by controlling the dosage of beta-catenin signaling. Nat. Genet. 2002, 32:594-605.
27. Korchynskyi O., ten D.P. Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J. Biol. Chem. 2002, 277:4883-4891.
28. Labbe E., Letamendia A., Attisano L. Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways. Proc. Natl. Acad. Sci. USA 2000, 97:8358-8363.
29. Lavery K., Hawley S., Swain P., Rooney R., Falb D., Aoui-Ismaili M.H. New insights into BMP-7 mediated osteoblastic differentiation of primary human mesenchymal stem cells. Bone 2009, 45:27-41.
30. Lian J.B., Stein G.S., Javed A., van Wijnen A.J., Stein J.L., Montecino M., Hassan M.Q., Gaur T., Lengner C.J., Young D.W. Networks and hubs for the transcriptional control of osteoblastogenesis. Rev. Endocr. Metab. Disord. 2006, 7:1-16.
31. Liu F., Kohlmeier S., Wang C.Y. Wnt signaling and skeletal development. Cell. Signal. 2008, 20:999-1009.
32. Liu Z., Tang Y., Qiu T., Cao X., Clemens T.L. A dishevelled-1/Smad1 interaction couples WNT and bone morphogenetic protein signaling pathways in uncommitted bone marrow stromal cells. J. Biol. Chem. 2006, 281:17156-17163.
33. Maretto S., Cordenonsi M., Dupont S., Braghetta P., Broccoli V., Hassan A.B., Volpin D., Bressan G.M., Piccolo S. Mapping Wnt/beta-catenin signaling during mouse development and in colorectal tumors. Proc. Natl. Acad. Sci. USA 2003, 100:3299-3304.
34. Mbalaviele G., Sheikh S., Stains J.P., Salazar V.S., Cheng S.L., Chen D., Civitelli R. Beta-catenin and BMP-2 synergize to promote osteoblast differentiation and new bone formation. J. Cell. Biochem. 2005, 94:403-418.
35. R.L. Miclea, E.C. Robanus-Maandag, J.J. Goeman, L. Finos, H. Bloys, C.W.G.M. Löwik, J.M. Wit, M. Karperien. Inhibition of GSK3-beta induces loss of the chondrocytic phenotype and cartilage matrix degradation through activation of canonical Wnt signaling. submitted. 2010.
36. Miclea R.L., Karperien M., Bosch C.A., van der H.G., d.van V., Kobayashi T., Kronenberg H.M., Rawadi G., Akcakaya P., Lowik C.W., Fodde R., Wit J.M., Robanus-Maandag E.C. Adenomatous polyposis coli-mediated control of beta-catenin is essential for both chondrogenic and osteogenic differentiation of skeletal precursors. BMC Dev. Biol. 2009, 9:26.
37. Miclea R.L., Karperien M., Langers A.M., Robanus-Maandag E.C., van L.A., van der Hiel B., Stokkel M.P., Ballieux B.E., Oostdijk W., Wit J.M., Vasen H.F., Hamdy N.A. APC mutations are associated with increased bone mineral density in patients with familial adenomatous polyposis. J. Bone Miner. Res. 2010.
38. Morin P.J., Vogelstein B., Kinzler K.W. Apoptosis and APC in colorectal tumorigenesis. Proc. Natl. Acad. Sci. USA 1996, 93:7950-7954.
39. Nathke I.S. The adenomatous polyposis coli protein: the Achilles heel of the gut epithelium. Annu. Rev. Cell Dev. Biol. 2004, 20:337-366.
40. Neufeld K.L., White R.L. Nuclear and cytoplasmic localizations of the adenomatous polyposis coli protein. Proc. Natl. Acad. Sci. USA 1997, 94:3034-3039.
41. Park K.S., Jeon S.H., Kim S.E., Bahk Y.Y., Holmen S.L., Williams B.O., Chung K.C., Surh Y.J., Choi K.Y. APC inhibits ERK pathway activation and cellular proliferation induced by RAS. J. Cell Sci. 2006, 119:819-827.
42. Petersen C.P., Bordeleau M.E., Pelletier J., Sharp P.A. Short RNAs repress translation after initiation in mammalian cells. Mol. Cell 2006, 21:533-542.
43. Rao M.K., Pham J., Imam J.S., MacLean J.A., Murali D., Furuta Y., Sinha-Hikim A.P., Wilkinson M.F. Tissue-specific RNAi reveals that WT1 expression in nurse cells controls germ cell survival and spermatogenesis. Genes Dev. 2006, 20:147-152.
44. Rawadi G., Vayssiere B., Dunn F., Baron R., Roman-Roman S. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. J. Bone Miner. Res. 2003, 18:1842-1853.
45. Schneikert J., Behrens J. Truncated APC is required for cell proliferation and DNA replication. Int.J. Cancer 2006, 119:74-79.
46. Tang Y., Liu Z., Zhao L., Clemens T.L., Cao X. Smad7 stabilizes beta-catenin binding to E-cadherin complex and promotes cell-cell adhesion. J. Biol. Chem. 2008, 283:23956-23963.
47. ten Dijke P. Bone morphogenetic protein signal transduction in bone. Curr. Med. Res. Opin. 2006, 22(Suppl 1):S7-11.
48. Theil T., Aydin S., Koch S., Grotewold L., Ruther U. Wnt and Bmp signalling cooperatively regulate graded Emx2 expression in the dorsal telencephalon. Development 2002, 129:3045-3054.
49. G. van der Horst, K.E. de Rooij, J. Hoogendam, H.C.M. Sips, A.L. Feitsma, I. Que, L. van der Wee-Pals, C.W.G.M. Löwik, M. Karperien. Functional genomics, drug screening and biomaterial evaluation using mesenchymal progenitor cells. 2010.
50. van der Horst G., Farih-Sips H., Lowik C.W., Karperien M. Hedgehog stimulates only osteoblastic differentiation of undifferentiated KS483 cells. Bone 2003, 33:899-910.
51. van der Horst G., Farih-Sips H., Lowik C.W., Karperien M. Multiple mechanisms are involved in inhibition of osteoblast differentiation by PTHrP and PTH in KS483 Cells. J. Bone Miner. Res. 2005, 20:2233-2244.
52. van der Horst G., van der Werf S.M., Farih-Sips H., van Bezooijen R.L., Lowik C.W., Karperien M. Downregulation of Wnt signaling by increased expression of Dickkopf-1 and β2 is a prerequisite for late-stage osteoblast differentiation of KS483 cells. J. Bone Miner. Res. 2005, 20:1867-1877.
53. van Es J.H., Giles R.H., Clevers H.C. The many faces of the tumor suppressor gene APC. Exp. Cell Res. 2001, 264:126-134.
54. Weeraratna A.T., Jiang Y., Hostetter G., Rosenblatt K., Duray P., Bittner M., Trent J.M. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell 2002, 1:279-288.
55. Winkler D.G., Sutherland M.S., Ojala E., Turcott E., Geoghegan J.C., Shpektor D., Skonier J.E., Yu C., Latham J.A. Sclerostin inhibition of Wnt-3a-induced C3H10T1/2 cell differentiation is indirect and mediated by bone morphogenetic proteins. J. Biol. Chem. 2005, 280:2498-2502.
56. Yan Y., Tang D., Chen M., Huang J., Xie R., Jonason J.H., Tan X., Hou W., Reynolds D., Hsu W., Harris S.E., Puzas J.E., Awad H., O'Keefe R.J., Boyce B.F., Chen D. Axin2 controls bone remodeling through the beta-catenin-BMP signaling pathway in adult mice. J. Cell Sci. 2009, 122:3566-3578.